Cymbiotika

Cymbiotika is a supplement company that formulates vitamins, minerals and other nutritional products using liposomal delivery, in which nutrients are encapsulated in lipids intended to protect them through digestion and improve absorption. Products are sold largely in liquid and gel form, packaged as single-serve packets and pouches rather than pills, powders or gummies. The catalog includes Liposomal Glutathione, Liposomal Vitamin C, Liposomal Magnesium Complex, Liposomal Vitamin D3 + K2 + CoQ10, Liposomal Vitamin B12 + B6, Liposomal NAD+, Liposomal Brain Complex, Liposomal Advanced Creatine, Liposomal Sleep, Liposomal Elderberry, Liquid Colostrum, Irish Sea Moss, Mineral Shilajit, Molecular Hydrogen, Super Greens, The Omega, Metabolic Health, Liver Health+, ParaX and Topical Magnesium Oil Spray, alongside branded merchandise such as hats, apparel, tumblers and packet organizers. Retail prices for supplements on the company's site generally range from roughly $32 to $88 per unit before subscription discounts.

The company positions its products around clinical substantiation and ingredient quality, stating that it has run independent clinical trials on finished formulas and citing results including a reported 50% increase in glutathione levels over baseline after one dose, 71% of participants reporting better sleep after 14 days on its magnesium complex, and 3x better absorption from its liposomal technology versus standard supplements. Marketing emphasizes pharmaceutical-grade ingredients, vegan, gluten-free, sugar-free and US-made formulations with no fillers, and a 60-day money-back guarantee. Human biologist Gary Brecka is featured on the site endorsing the brand's ingredient and delivery standards.

Cymbiotika was co-founded by Durana Elmi, Shahab Elmi and Chervin Jafarieh. In November 2025 the company announced a $25 million seed round, its first outside funding, after bootstrapping to $150 million in annual revenue and five consecutive years of triple-digit growth.

Founding story

The company was co-founded by Durana Elmi, Shahab Elmi and Chervin Jafarieh around the premise that most supplements are poorly absorbed, and built its product line on liposomal delivery and clean, bioavailable formulations.

Business model

Cymbiotika sells packaged nutritional supplements to consumers. Its primary channel is its own e-commerce site, where purchases can be made one-time or on recurring subscriptions that carry tiered discounts (30% off for one subscription item, rising to 40% for four or more), free shipping and loyalty perks. The company also sells through Amazon, where products are offered with an additional subscribe-and-save discount, and through physical retail following a national launch in Target stores.

Revenue comes from product sales at premium price points, with subscription-based repeat purchasing incentivized by discounts of 30-40%, free shipping, free-gift thresholds (for example a free 12-pack at $110 spend) and a rewards program. Additional revenue comes from wholesale/retail distribution via Target and marketplace sales via Amazon, plus branded merchandise and gift cards.

Traction

The company reported $150 million in annual revenue and five consecutive years of triple-digit growth prior to its 2025 seed round, and its website cites more than 60,000 subscribers. Individual products carry thousands of on-site reviews, with Liposomal Glutathione at about 6,692 and Liposomal Magnesium Complex at about 5,933. Its Amazon store lists monthly purchase volumes including 6,000+ for Liposomal Glutathione and 2,000+ for Liposomal Magnesium Complex in the prior month.

Latest developments

Cymbiotika entered all Target stores nationwide in October 2025 and announced a $25 million seed round in November 2025 led by David Grutman, with more than 50 backers from music, sports and business. Concurrently it launched its first nationwide brand campaign and said the funding would accelerate retail expansion and functional nutrition innovation. Recent product additions include Liposomal NAD+ and Liposomal Advanced Creatine.